Français
ItalianoBond AbbVie 0% ( US00287YBP34 ) in USD
| Issuer | AbbVie | ||||||||
| Market price | 99.97 % ▼ | ||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US00287YBP34 ( in USD )
|
||||||||
| Interest rate | 0% | ||||||||
| Maturity | 21/11/2022 - Bond has expired | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | 2 000 USD | ||||||||
| Total amount | 739 760 000 USD | ||||||||
| Cusip | 00287YBP3 | ||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. AbbVie's USD 739,760,000 0% bond (ISIN: US00287YBP34, CUSIP: 00287YBP3), issued in the United States, matured on November 21, 2022, and has been redeemed at 99.9658% of face value, with a minimum trading size of 2,000 bonds and a semi-annual coupon payment frequency. |
||||||||
| |||||||||